- Home
- EOS vs AVDL Comparison
EOS vs AVDL Comparison
Compare EOS & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOS
- AVDL
- Stock Information
- Founded
- EOS 2005
- AVDL 2015
- Country
- EOS United States
- AVDL Ireland
- Employees
- EOS N/A
- AVDL N/A
- Industry
- EOS Trusts Except Educational Religious and Charitable
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- EOS Finance
- AVDL Health Care
- Exchange
- EOS Nasdaq
- AVDL Nasdaq
- Market Cap
- EOS 1.2B
- AVDL 1.4B
- IPO Year
- EOS N/A
- AVDL 1996
- Fundamental
- Price
- EOS $22.73
- AVDL $10.91
- Analyst Decision
- EOS
- AVDL Strong Buy
- Analyst Count
- EOS 0
- AVDL 6
- Target Price
- EOS N/A
- AVDL $24.00
- AVG Volume (30 Days)
- EOS 84.1K
- AVDL 1.5M
- Earning Date
- EOS 01-01-0001
- AVDL 11-12-2024
- Dividend Yield
- EOS 6.80%
- AVDL N/A
- EPS Growth
- EOS N/A
- AVDL N/A
- EPS
- EOS N/A
- AVDL N/A
- Revenue
- EOS N/A
- AVDL $138,160,000.00
- Revenue This Year
- EOS N/A
- AVDL $533.23
- Revenue Next Year
- EOS N/A
- AVDL $73.08
- P/E Ratio
- EOS N/A
- AVDL N/A
- Revenue Growth
- EOS N/A
- AVDL 1523.50
- 52 Week Low
- EOS $15.62
- AVDL $10.41
- 52 Week High
- EOS $20.63
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- EOS 56.76
- AVDL 31.84
- Support Level
- EOS $22.85
- AVDL $14.45
- Resistance Level
- EOS $23.25
- AVDL $16.66
- Average True Range (ATR)
- EOS 0.26
- AVDL 0.95
- MACD
- EOS 0.01
- AVDL -0.41
- Stochastic Oscillator
- EOS 58.33
- AVDL 4.80
About EOS Eaton Vance Enhance Equity Income Fund II
Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. It invests in a portfolio of large and mid-cap securities in the sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.